Ratchaphruek Hospital PCL (BKK:RPH)

Ratchaphruek Hospital PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	1,139	1,125	1,161	1,326	1,413	799.33
Revenue Growth (YoY)	-0.61%	-3.05%	-12.49%	-6.12%	76.72%	-2.11%
Cost of Revenue	757.23	751.44	750.58	827.01	746.98	566.64
Gross Profit	381.5	373.73	410.01	499.17	665.58	232.69
Selling, General & Admin	185.78	181.22	191.46	149.5	167.72	121.58
Operating Expenses	184.7	181.22	191.46	149.5	167.72	121.58
Operating Income	196.79	192.51	218.55	349.67	497.86	111.11
Interest Expense	-0.55	-0.57	-2.11	-5.55	-6.69	-7.83
Interest & Investment Income	6.58	6.58	2.78	0.81	0.35	0.35
Other Non Operating Income (Expenses)	17.85	17.85	14.16	13.26	11.54	12.86
EBT Excluding Unusual Items	220.68	216.37	233.38	358.19	503.07	116.49
Pretax Income	220.68	216.37	233.38	358.19	503.07	116.49
Income Tax Expense	47.27	43.84	48.92	71.73	100.07	22.64
Net Income	173.4	172.53	184.45	286.47	402.99	93.84
Net Income to Common	173.4	172.53	184.45	286.47	402.99	93.84
Net Income Growth	-1.02%	-6.46%	-35.61%	-28.92%	329.43%	-2.67%
Shares Outstanding (Basic)	537	546	546	546	546	546
Shares Outstanding (Diluted)	537	546	546	546	546	546
Shares Change (YoY)	-1.62%	-0.01%	-	-	-	-
EPS (Basic)	0.32	0.32	0.34	0.52	0.74	0.17
EPS (Diluted)	0.32	0.32	0.34	0.52	0.74	0.17
EPS Growth	0.61%	-6.46%	-35.61%	-28.92%	329.43%	-2.67%
Free Cash Flow	187.07	230.62	342.38	420.32	271.25	131.88
Free Cash Flow Per Share	0.35	0.42	0.63	0.77	0.50	0.24
Dividend Per Share	0.280	0.290	0.300	0.350	0.300	0.130
Dividend Growth	-6.67%	-3.33%	-14.29%	16.67%	130.77%	-7.14%
Gross Margin	33.50%	33.22%	35.33%	37.64%	47.12%	29.11%
Operating Margin	17.28%	17.11%	18.83%	26.37%	35.24%	13.90%
Profit Margin	15.23%	15.33%	15.89%	21.60%	28.53%	11.74%
Free Cash Flow Margin	16.43%	20.50%	29.50%	31.69%	19.20%	16.50%
EBITDA	271.09	266.91	303.46	440.29	584.49	197.85
EBITDA Margin	23.81%	23.72%	26.15%	33.20%	41.38%	24.75%
D&A For EBITDA	74.3	74.4	84.91	90.62	86.62	86.74
EBIT	196.79	192.51	218.55	349.67	497.86	111.11
EBIT Margin	17.28%	17.11%	18.83%	26.37%	35.24%	13.90%
Effective Tax Rate	21.42%	20.26%	20.96%	20.02%	19.89%	19.44%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.